SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2510)6/12/2009 9:15:25 AM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
CRXX is up 43.21% in pre-market trading.

The stock is trading at $1.16 above its May H

bigcharts.marketwatch.com

It announced the presentation of full data on Synavive (CRx-102) PII at the Annual European Congress of Rheumatology in Copenhagen on June 12, 2009. The presentation, “CRx-102, a dissociated glucocorticoid and prednisolone provide safe and effective pain relief in knee osteoarthritis.

Bernard



To: Jibacoa who wrote (2510)6/17/2009 9:45:12 AM
From: Jibacoa  Respond to of 3722
 
SVNT is up 29.45% on volume already close to 2M.<g>

Yesterday the FDA panel of arthritis experts said thatn its gout drug should be approved, despite some reports of heart problems in patients tested with the drug and in AHs trading the stock jumped 28.3% to $11.89.

bigcharts.marketwatch.com

Bernard


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News